0.9(top 50%)
impact factor
319(top 50%)
papers
304(top 50%)
citations
8(top 50%)
h-index
0.9(top 50%)
extended IF
326
all documents
309
doc citations
15(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSIONEurasian Heart Journal202054
2EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)Eurasian Heart Journal202028
3DIAGNOSTICS AND TREATMENT OF ARTERIAL HYPERTENSIONEurasian Heart Journal201522
4EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)Eurasian Heart Journal202120
5EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION (STEMI)Eurasian Heart Journal202017
6EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATIONEurasian Heart Journal201913
7DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISM EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) CLINICAL PRACTICE GUIDELINES (2021)Eurasian Heart Journal202112
8EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)Eurasian Heart Journal20219
9EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)Eurasian Heart Journal20206
10Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022)Eurasian Heart Journal20226
11MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTIONEurasian Heart Journal20205
12Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)Eurasian Heart Journal20214
13ACCORDING TO THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015: NEW VERSION OF GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSIONEurasian Heart Journal20154
14OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPERTENSION: THE POSSIBILITIES OF USING ENDOTHELIN RECEPTOR ANTAGONISTSEurasian Heart Journal20174
15Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)Eurasian Heart Journal20233
16Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiationEurasian Heart Journal20233
17CARDIOLOGICAL ASPECTS OF THE PERIOPERATIVE MANAGEMENT OF PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION FOR PULMONARY THROMBOENDARTERECTOMYEurasian Heart Journal20212
18THE POSSIBILITY OF USING ELECTRONIC MEDICAL RECORDS FOR CLINICAL OBSERVATIONEurasian Heart Journal20212
19INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?Eurasian Heart Journal20202
20EFFICACY OF IVABRADINE THERAPY ON RIGHT HEART PARAMETERS AND PROGNOSIS IN PATIENTS WITH SEVERE SYSTOLIC CHRONIC HEART FAILUREEurasian Heart Journal20122
21COMBINATION THERAPY OF ARTERIAL HYPERTENSION - OUR EXPECTATIONSEurasian Heart Journal20132
22Pulmonary arterial hypertension: challenges and achievements 2021Eurasian Heart Journal20222
23ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOXEurasian Heart Journal20192
24VALUE OF VOLUME FRACTION OF COLLAGEN IN DEVELOPMENT OF MYOCARDIUM REMODELING ATTHE PATIENTS WITH INFLAMMATORY CARDIOMYOPATHYEurasian Heart Journal20142
25GLOMERULAR FILTRATION RATE AS A MARKER OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSIONEurasian Heart Journal20142
26APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSIONEurasian Heart Journal20152
27INNOVATION IN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: STIMULATOR OF SOLUBLE GYANYLATE CYCLASE - RIOCIGUATEurasian Heart Journal20152
28THE ROLE OF ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM IN THE PATHOGENESIS OF ARTERIAL HYPERTENSION AND THE CHOICE OF A METHOD FOR THE TREATMENT OF ARTERIAL HYPERTENSIONEurasian Heart Journal20182
29APPLICATION OF NEW ECHOCARDIOGRAPHIC TECHNOLOGIES OF NON-DOPPLER MYOCARDIAL IMAGES IN 2D AND 3D MODES IN PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTIONEurasian Heart Journal20172
30FEATURES OF CUTANEOUS MICROCIRCULATORY BLOOD FLOW IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION ASSESSED BY LASER DOPPLER FLOWMETRY DEPENDING ON VASOREACTIVITY STATUS ON INHALED NITRIC OXIDEEurasian Heart Journal20162
31IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROMEEurasian Heart Journal20172
32EVALUATION OF DEFORMATION OF THE LEFT VENTRICLE AND LEFT ATRIUM, AND THE ROTATIONAL PROPERTIES OF THE LEFT VENTRICLE IN PATIENTS WITH CHF ACCORDING TO THE ECHOCARDIOGRAPHIC TECHNOLOGY OF NON-DOPPLER IMAGING IN TWO AND THREE-DIMENSIONAL REGIMENSEurasian Heart Journal20182
33MODERN APPROACHES TO DETECTING EARLY SUBCLINICAL CARDIOTOXICITY INDUCED BY CHEMOTHERAPY IN PATIENTS WITH BREAST CANCEREurasian Heart Journal20182
34PECULIARITIES AND SURGICAL TREATMENT TACTICS OF POSTERO-BASAL LEFT VENTRICULAR ANEURYSMSEurasian Heart Journal20182
35Possibility of evaluation of oxygen transport function in PAH patients on effective selexipag-based therapyEurasian Heart Journal20232
36METABOLOMIC APPROACHES IN STUDYING OF CARDIOVASCULAR DISEASESEurasian Heart Journal20211
37ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHYEurasian Heart Journal20211
38Evidence born from ASCOT trial – still important after 15 yearsEurasian Heart Journal20211
39Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)Eurasian Heart Journal20211
40PHARMACOEPIDEMIOLOGY OF USING OF ANTIHYPERTENSIVE DRUGS BY FAMILY PHYSICIANSEurasian Heart Journal20201
41STRUCTURAL CHANGES OF THE PULMONARY ARTERIES AFTER BALLOON PULMONARY ANGIOPLASTY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSIONEurasian Heart Journal20201
42CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND 1-YEAR PROGNOSISEurasian Heart Journal20201
43MARKERS OF RISK FACTORS FOR CARDIOVASCULAR DISEASEEurasian Heart Journal20201
44SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVALEurasian Heart Journal20151
45INVERSION OF THE CONCEPT ABOUT BIOLOGICAL ROLE OF RENIN → ANGIOTENSIN-II → ALDOSTERONE SYSTEM AND FUNCTION OF ARTERIAL BLOOD PRESSURE AS A METABOLISM REGULATOREurasian Heart Journal20151
46CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATORS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION, DEPENDING ON VASOREACTIVITY RESERVE OF PULMONARY ARTERIESEurasian Heart Journal20161
47THE INFLUENCE OF OBSTRUCTIVE SLEEP APNEA AND PRIMARY SNORING ON CARDIAC ARRHYTHMIAS AND HEART RHYTHM VARIABILITY IN PATIENTS WITH ISCHEMIC HEART DISEASEEurasian Heart Journal20161
48PSYCHO-EMOTIONAL CHANGES IN PATIENTS WITH CHRONIC HEART FAILUREEurasian Heart Journal20161
49DYAGNOSIS AND TREATMENT OF CARDIAC PULMONARY OEDEMAEurasian Heart Journal20121
50ROLE OF THE PPARГ PROI2ALA POLYMORPHISM IN HYPERTENSION AND METABOLIC SYNDROMEEurasian Heart Journal20121